The Frontier
Science & tech breakthroughs in AI models, hardware, and computing that define what's possible
📍 The Signal
Elon Musk’s xAI Raises $20 Billion. Elon Musk’s startup xAI secured US$20 billion in new funding as investors race to back large-scale AI model developers at unprecedented valuations. The raise marks one of the biggest private capital injections in the sector to date.
📍 The Signal
Meta’s Manus news is getting different receptions in Washington and Beijing. Meta agreed to buy Singapore-based AI assistant developer Manus for US$2 billion. U.S. regulators signaled no objection after earlier scrutiny of American investments in Chinese AI firms, while Chinese authorities have opened a review of the transaction following Manus’s relocation from Beijing to Singapore.
Capital & Control
Tracking the flow of capital and influence that shapes the tech landscape
📍 The Signal
Intel spinout Articul8 raises more than half of $70M round at $500M valuation. Articul8, Intel’s 2024 enterprise-AI spinout, has secured the first tranche of a two-part $70 million Series B at a $500 million pre-money valuation—a five-fold jump from its January 2024 Series A. The company reports $90 million in contracted revenue across 29 customers in regulated sectors.
Infrastructure & Power
The physical backbone of AI: compute, data centers, supply chains, and the geopolitics of energy
📍 The Signal
Nvidia Details New A.I. Chips and Autonomous Car Project With Mercedes. Nvidia introduced its next-generation Vera Rubin AI accelerator at CES, promising higher efficiency and performance than current Hopper GPUs and setting shipments for later this year. The company also disclosed a partnership with Mercedes-Benz to deploy its new Alpamayo ‘reasoning’ platform in an upcoming driverless car line.
The Performance Edge
Peak performance science for sustained execution in high-stakes environments
📍 The Signal
This weight loss option beats Ozempic by 5 times. A real-world registry study of 50,000 patients found bariatric surgery produced an average 58-pound loss two years post-procedure, versus roughly 12 pounds for users of GLP-1 drugs such as semaglutide and tirzepatide. Even among patients who stayed on medication for a full year, surgery delivered five-times greater and more durable weight reduction.
Digital Defense
Threats and defenses shaping the global security landscape
📍 The Signal
New Veeam vulnerabilities expose backup servers to RCE attacks. Veeam released security updates after disclosing CVE-2025-59470, a remote-code-execution flaw in Veeam Backup & Replication v13 and earlier that can be triggered by users holding Backup or Tape Operator roles. The patch set (build 13.0.1.245) also addresses additional high-severity issues affecting backup infrastructure.
About this newsletter
The content you just read was autonomously curated, analyzed, and published by an AI agent I built. It runs on a Raspberry Pi and operates via a GitHub workflow. I don't write it, I just orchestrate the system.
You can follow my work at gurj.ai or connect with me on LinkedIn.